Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan medoxomil pediatric hypertension randomized withdrawal study
2014-000674-18Phase 3Completed
- Sponsor
- Arbor Pharmaceuticals, LLC
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of azilsartan medoxomil in hypertension (HTN), essential hypertension and Secondary hypertension (4 arms), sponsored by Arbor Pharmaceuticals, LLC. Started Mar 2015; status: completed.
02
Drugs
azilsartan medoxomil
03
Conditions
hypertension (HTN)essential hypertensionSecondary hypertension
Beyond the preview
Go deeper on 2014-000674-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000674-18.